Melanoma is the deadliest form of skin cancer, responsible for around three quarters of skin cancer fatalities; each hour, someone dies from melanoma in the United States. However, when detected early, the disease is nearly 100% curable.
MelaFind is an FDA-approved optical imaging and data analysis device that helps a dermatologist gather information to determine whether to biopsy an irregular mole. Using light of 10 different wavelengths, the device takes noninvasive spectral imaging that offers 100% objective data. Then, sophisticated computer software analyzes the mole and informs the dermatologist of irregular growth patterns under the skin. This allows the dermatologist to more accurately identify melanoma in its early, most curable stages.